Chescapmanager’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-197,000
Closed -$34.9M 49
2020
Q1
$34.9M Hold
197,000
8.53% 2
2019
Q4
$37.7M Hold
197,000
5.54% 3
2019
Q3
$33.2M Buy
197,000
+70,000
+55% +$11.4M 4.72% 4
2019
Q2
$21.3M Hold
127,000
2.12% 12
2019
Q1
$18.6M Buy
127,000
+16,000
+14% +$2.32M 2.21% 14
2018
Q4
$14.8M Sell
111,000
-23,400
-17% -$3.84M 3.58% 11
2018
Q3
$25.6M Sell
134,400
-20,000
-13% -$3.67M 2.62% 7
2018
Q2
$25.7M Buy
154,400
+15,000
+11% +$2.41M 2.98% 7
2018
Q1
$23.5M Buy
139,400
+77,000
+123% +$12.9M 3.5% 4
2017
Q4
$10.2M Buy
62,400
+18,400
+42% +$3.3M 1.66% 25
2017
Q3
$9.02M Buy
44,000
+5,000
+13% +$1.16M 1.75% 24
2017
Q2
$9.48M Sell
39,000
-20,000
-34% -$4.7M 1.6% 22
2017
Q1
$14.1K Sell
59,000
-2,000
-3% -$466K 1.93% 11
2016
Q4
$12.8M Buy
+61,000
New +$12.6M 4.7% 5

Other funds holding AGN

Chescapmanager's AGN Position: Q2 2020 in Review

Chescapmanager sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 197,000 shares — an estimated $34.9M sold.

Chescapmanager first reported a position in AGN in Q4 2016 and held it in 14 quarters. The position peaked at $37.7M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Chescapmanager reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Chescapmanager sold 197,000 Allergan plc shares in Q2 2020, an estimated $34.9M.
  • Chescapmanager first reported a position in Allergan plc in Q4 2016 and held it in 14 quarters.
  • Chescapmanager's Allergan plc position peaked at $37.7M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Chescapmanager's 13F filing for Q2 2020, filed 14 Aug 2020.